3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
1
Metabolic Syndrome
1
Heart Failure
1
Cardiovascular Diseases
1
Interventions
sacubitril and valsartan sodium hydrate drug combination
2
dapagliflozin
2
Rituximab
2
pertuzumab
1
pegfilgrastim
1
obinutuzumab
1
nicotinamide-beta-riboside
1
acalabrutinib
1
Vincristine
1
Valsartan
1
Trastuzumab
1
Standard of Care
1
Specimen Handling
1
Pyruvic Acid
1
Prednisolone
1
Practice Guidelines as Topic
1
Ogivri
1
Mesenchymal Stem Cell Transplantation
1
Lenalidomide
1
Eplerenone
1
Electronic Health Records
1
Echocardiography
1
Doxorubicin
1
Dexrazoxane
1
Cyclophosphamide
1
Cardiac Resynchronization Therapy
1
Angiotensin-Converting Enzyme Inhibitors
1
Adrenergic beta-Antagonists
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Heart Failure
×
Pyruvic Acid
×
Clear all
NCT06645691
2024-12-06
POLARIC-13
National Heart Centre Singapore
Phase 2
Recruiting
200 enrolled